Table 3.
Visual Outcomes After Intraocular Inflammation Adverse Events
Intraocular inflammation AE (MedDRA preferred term) | Treatment arm | Worst change from baseline BCVA after AE (letters) | BCVA change from baseline at escape to SoC or study exit (letters) |
---|---|---|---|
Iritis | Abicipar 1 mg | −5 | −1 |
Uveitis | Abicipar 1 mg | −2 | +4 |
Vitritis | Abicipar 1 mg | +14 | +22 |
Iritis | Abicipar 2 mg | NA | +2 |
Choroiditis | Abicipar 2 mg | −19 | +7 |
AE, adverse event; BCVA, best-corrected visual acuity; MedDRA, medical dictionary for regulatory activities; NA, not available; SoC, standard of care.